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Metastatic left atrial synovial sarcoma mimicking a myxoma
Sanjay Kumar, MCh, FRCS,a Mubarak A. Chaudhry, FRCS,a Irfan Khan, MRCS,a David J. R. Duthie, MD, FRCA,b,a Leeds and Bradford, United KingdomHeart neoplasms are of increasing interest to cliniciansand surgeons. A synovial sarcoma of the heart, eitherprimary or secondary in origin, is extremely uncom-mon.1 To our knowledge, this report is the first doc-
umented metastatic synovial sarcoma of the left atrium and em-
phasizes that this tumor, although rare, should be considered in the
differential diagnosis of left atrial myxoma. The pathology, clini-
cal implication, and management options are discussed.
Clinical Summary
A 27-year-old man presented with a 4-month history of palpita-
tions and dyspnea. Of note, there was no history of syncope,
constitutional symptoms, or previous asbestos exposure. Within
the last few weeks, he had also noticed a tender swelling in his
right calf. Apart from the presence of the calf swelling, his phys-
ical examination was unremarkable. Transthoracic echocardiogra-
phy showed a 4  2.5–cm mass arising from the mitral valve and
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consistent with that of a myxoma, although its site of origin was
unusual.
The patient was admitted expeditiously for excision of the left
atrial mass. Through a median sternotomy, cardiopulmonary by-
pass was established after aortobicaval cannulation. The heart was
arrested with antegrade cold blood cardioplegia. An atriotomy was
made in a large left atrium behind the interatrial groove. A large 3
 3.5–cm, dumbbell-shaped mass was present in the left atrium.
It had a wide origin, arising from the posterior mitral leaflet,
posteromedial commissure, adjoining anterior mitral leaflet, and
left atrial wall posteriorly. The mass (Figure 2) could not be
excised without sacrificing the mitral valve, which was replaced
with a 29-mm St Jude mechanical prosthesis. There was a possi-
bility of incomplete resection because the tumor was invading the
atrioventricular groove. The patient had an uneventful postopera-
tive recovery.
The histopathologic examination revealed a tumor of mixed
cellularity set within focally calcified fibrous stroma–positive mar-
gin. Morphologic and immunocytochemical features of the tumor
were consistent with the diagnosis of synovial sarcoma. A cyto-
genetic examination of the excised lesion demonstrated an abnor-
mal triploid clone containing 2 copies of translocation t(X; 18),
which is consistent with the above diagnosis.
After histologic diagnosis of the cardiac tumor, the patient
underwent a contrast spiral computed tomographic scan of the
thorax, abdomen, and pelvis. No further intrathoracic or intra-
abdominal lesion was seen. An ultrasound scan of the right calf
swelling suggested a discrete lesion with its own intrinsic blood
flow, which is consistent with it being a sarcoma. A tru-cut biopsy
confirmed this to be a synovial sarcoma. Which lesion, either left
atrial or right calf, was the primary and which was the secondary
was impossible to determine both histologically and clinically. The
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primary source cannot be discounted.
The patient received ifosfamide-based chemotherapy. This
comprised 9 g/m2 ifosfamide every 3 weeks for 2 cycles. A spiral
computed tomographic scan was performed after completing 2
cycles. Two new areas of abnormalities were seen: a 2-mm nodule
in the right lower lobe of the lung and a cluster of small lymph
nodes adjacent to the left kidney. A new subcutaneous soft tissue
swelling was also present in the right loin posteriorly. The patient
was offered second-line chemotherapy with doxorubicin with or
without trial agents, but he elected to explore alternative therapies.
Discussion
Tumors of the heart are rare and are usually benign, with the
majority being myxomas. Only 25% of primary cardiac tumors are
malignant, and nearly all are sarcomas. The most common are
angiosarcomas (31%), followed by rhabdomyosarcomas (21%),
malignant mesotheliomas (15%), and fibrosarcomas (11%), with
synovial sarcomas being extremely rare.1,2 However, the most
common cardiac malignancy is a metastatic cardiac tumor, being
20 to 40 times more common than primary cardiac malignancies.1
The synovial sarcoma itself is an uncommon mesenchymal
malignant tumor with epithelial qualities.1 The most common
primary site for a synovial sarcoma is the lower limb, usually in the
para-articular regions. An occurrence outside the synovial-lined
spaces is rare, and only a limited number of cases have been
documented. They are also known to arise within the abdominal
wall, neck, head, mediastinum, lung, or pleura. On rare occasions,
these are known to arise within the heart.
There are 7 published reports of primary cardiac synovial
sarcomas in patients ranging from 13 to 53 years of age (mean,
40.8 years).1,3 Most of these patients presented with syncope or
dyspnea. There is an association with previous exposure to asbes-
tos.4 These patients might be asymptomatic or might present with
transient ischemic attack, pulmonary hypertension, heart failure, or
cardiac tamponade, symptoms dependent on location within the
Figure 1. Transesophageal echocardiogram showing th
mitral leaflet (AML) in systole; B, protruding through th
diastole. The left ventricle (LV), right atrium (RA), andheart and associated pathology.5-8 Sarcomas present in the left
The Journal of Thoraciatrium can be easily mistaken for left atrial myxomas because
echocardiographically they are indistinguishable.4,5 To date, no
report of a metastatic arial synovial sarcoma has been published.
Because primary synovial sarcomas commonly arise at extracar-
diac sites, it is likely that in this case the calf lesion is the primary
lesion, with metastatic spread to the heart.
The diagnosis of a synovial carcinoma is confirmed by means
of identification of a chromosomal translocation, t(X; 18), which is
found in more than 90% of all synovial sarcomas. The distinction
between a synovial sarcoma and a primary cardiac mesothelioma
of the heart is difficult, and therefore it is important to confirm the
t(X;18) translocation to verify the diagnosis.1,3,4
For primary intracardiac sarcomas with no evidence of meta-
static spread, surgical intervention is the mainstay of treatment not
only to alleviate symptoms but also to avoid potential complica-
Figure 2. The excised tumor is shown, and the arrow points to the
end of the tumor attached to the left atrial wall, the leaflets, and
the posteromedial commissure of the mitral valve.
or (T) in the left atrium (LA): A, attached to the anterior
tral valve orifice close to the anterior mitral leaflet in
ventricle (RV) are also shown.e tum
e mitions. As in this case, excision of a valve might be necessary to
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section is possible in only 33% of patients.9 Invasion of the
atrioventricular groove by tumor in this case made complete re-
section impossible. Recurrence is common even in patients with
apparent complete excision.9 After surgical intervention, adjuvant
radiotherapy for local recurrence and chemotherapy for control of
systemic disease might be considered. Heart-lung transplantation
has been reported as an option for cure in patients with primary
cardiac synovial sarcomas with no evidence of metastatic spread.10
This was not an option in our patient because of the likely meta-
static involvement of the heart.
Synovial sarcoma of the heart is a disease of young people and
carries a poor prognosis. In most reported cases, patients succumb
within 1 year of diagnosis.1 The most common cause of death is
local recurrence (50%), even after complete macroscopic resec-
tion.9 The aggressive nature of the disease might require modifi-
cation of accepted treatment modalities and sequence.
In retrospect, the unusual echocardiographic features (ie, at-
tachment to the mitral leaflet) in our patient should have raised
suspicion. A cardiac magnetic resonance image might have pro-
vided more detailed anatomic information and suggested histolo-
gy.11 It can be argued that the usual paradigm of treating potential
myxomas urgently should have been disregarded, with the calf
lesion investigated first. One cannot help but postulate that cardio-
pulmonary bypass in this instance might have hastened the dis-
semination of the tumor.
Conclusion
Metastatic synovial sarcoma to the left atrium carries a grave
prognosis. It should be considered in the differential diagnosis of
left atrial myxomas, especially if the echocardiography suggests
unusual features.
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